The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease: a multicentre European Scleroderma Trials and Research group (EUSTAR) study.
published in: Rheumatology
date of publication: 2017-05-01
main subject: multicenter clinical trial, interstitial lung disease
Cites articles 27
- 2011-02-23
Date
Title
Article - wd:Q47981856